FDA Import Refusal AEK-6367885-5/11/1 — Janssen Pharmaceuticals Inc.
The FDA refused shipment AEK-6367885-5/11/1 from Janssen Pharmaceuticals Inc. (United States) on Oct 1, 2019. The refused product falls under Drugs and Biologics — CANAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 1, 2019
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PAY69 CANAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75